Schuster AK, Erb C, Hoffmann EM, Dietlein T, Pfeiffer N (2020) The diagnosis and treatment of glaucoma. Dtsch Arztebl Int 117(13):225–234. https://doi.org/10.3238/arztebl.2020.0225

Article  PubMed  Google Scholar 

Kang JM, Tanna AP (2021) Glaucoma. Med Clin North Am 105(3):493–510. https://doi.org/10.1016/j.mcna.2021.01.004

Article  PubMed  Google Scholar 

Stein JD, Khawaja AP, Weizer JS (2021) Glaucoma in adults-screening, diagnosis, and management: a review. JAMA 325(2):164–174. https://doi.org/10.1001/jama.2020.21899

Article  PubMed  Google Scholar 

Huang Y, Xu W, Zhou R (2021) NLRP3 inflammasome activation and cell death. Cell Mol Immunol 18(9):2114–2127. https://doi.org/10.1038/s41423-021-00740-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Hauenstein AV (2020) The NLRP3 inflammasome: mechanism of action, role in disease and therapies. Mol Aspects Med 76:100889. https://doi.org/10.1016/j.mam.2020.100889

Article  CAS  PubMed  Google Scholar 

Wang M, Pan W, Xu Y, Zhang J, Wan J, Jiang H (2022) Microglia-mediated neuroinflammation: a potential target for the treatment of cardiovascular diseases. J Inflamm Res 15:3083–3094. https://doi.org/10.2147/JIR.S350109

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen S, Wang Z, Sun H, Ma L (2022) Role of NLRP3 inflammasome in myocardial ischemia-reperfusion injury and ventricular remodeling. Med Sci Monit 28:e934255. https://doi.org/10.12659/MSM.934255

Article  CAS  PubMed  PubMed Central  Google Scholar 

8, Minutoli L, Puzzolo D, Rinaldi M, Irrera N, Marini H, Arcoraci V, Bitto A, Crea G et al (2016) ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia/reperfusion injury. Oxid Med Cell Longev 2016:2183026. https://doi.org/10.1155/2016/2183026

Toldo S, Abbate A (2018) The NLRP3 inflammasome in acute myocardial infarction. Nat Rev Cardiol 15(4):203–214. https://doi.org/10.1038/nrcardio.2017.161

Article  CAS  PubMed  Google Scholar 

Ulasov AV, Rosenkranz AA, Georgiev GP, Sobolev AS (2022) Nrf2/Keap1/ARE signaling: towards specific regulation. Life Sci 291:120111. https://doi.org/10.1016/j.lfs.2021.120111

Article  CAS  PubMed  Google Scholar 

Saha S, Buttari B, Panieri E, Profumo E, Saso L (2020) An overview of Nrf2 signaling pathway and its role in inflammation. Molecules 25(22). https://doi.org/10.3390/molecules25225474

Panisello-Roselló GBR, Sanchez-Nuno A, Alva S, Roselló-Catafau N, Carbonell J T (2022) Nrf2 and oxidative stress in liver ischemia/reperfusion injury. Febs J 289(18):5463–5479. https://doi.org/10.1111/febs.16336

Article  CAS  PubMed  Google Scholar 

Yu C, Xiao JH (2021) The Keap1-Nrf2 system: a mediator between oxidative stress and aging. Oxid Med Cell Longev 2021:6635460. https://doi.org/10.1155/2021/6635460

Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J (2016) Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci 73(17):3221–3247. https://doi.org/10.1007/s00018-016-2223-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Q, Liu J, Duan H, Li R, Peng W, Wu C (2021) Activation of Nrf2/HO-1 signaling: an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. J Adv Res 34:43–63. https://doi.org/10.1016/j.jare.2021.06.023

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang C, Zhao M, Wang B, Su Z, Guo B, Qin L, Zhang W, Zheng R (2021) The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of celastrol in Parkinson’s disease. Redox Biol 47:102134. https://doi.org/10.1016/j.redox.2021.102134

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bian H, Wang G, Huang J, Liang L, Zheng Y, Wei Y, Wang H, Xiao L et al (2020) Dihydrolipoic acid protects against lipopolysaccharide-induced behavioral deficits and neuroinflammation via regulation of Nrf2/HO-1/NLRP3 signaling in rat. J Neuroinflammation 17(1):166. https://doi.org/10.1186/s12974-020-01836-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Y, Qiu G, Zhang H, Zhu L, Cheng G, Wang Y, Li Y, Wu W (2021) Dexmedetomidine alleviates hepatic ischaemia-reperfusion injury via the PI3K/AKT/Nrf2-NLRP3 pathway. J Cell Mol Med 25(21):9983–9994. https://doi.org/10.1111/jcmm.16871

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao L, Dai Z, Tang W, Liu C, Tang B (2021) Astragaloside IV alleviates cerebral ischemia-reperfusion injury through NLRP3 inflammasome-mediated pyroptosis inhibition via activating Nrf2. Oxid Med Cell Longev 2021:9925561. https://doi.org/10.1155/2021/9925561

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng Y, Cheng L, Gao X, Chen S, Wu P, Wang C, Liu Z (2021) Covalent modification of Keap1 at Cys77 and Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3 inflammasome activation in myocardial ischemia-reperfusion injury. Theranostics 11(2):861–877. https://doi.org/10.7150/thno.48436

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qi Y, Zhao M, Bai Y, Huang L, Yu W, Bian Z, Zhao M, Li X (2014) Retinal ischemia/reperfusion injury is mediated by toll-like receptor 4 activation of NLRP3 inflammasomes. Invest Ophthalmol Vis Sci 55(9):5466–5475. https://doi.org/10.1167/iovs.14-14380

Article  CAS  PubMed  Google Scholar 

Su CF, Jiang L, Zhang XW, Iyaswamy A, Li M (2021) Resveratrol in rodent models of Parkinson’s disease: a systematic review of experimental studies. Front Pharmacol 12:644219. https://doi.org/10.3389/fphar.2021.644219

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hecker A, Schellnegger M, Hofmann E, Luze H, Nischwitz SP, Kamolz LP, Kotzbeck P (2022) The impact of resveratrol on skin wound healing, scarring, and aging. Int Wound J 19(1):9–28. https://doi.org/10.1111/iwj.13601

Article  PubMed  Google Scholar 

Khorshidi F, Poljak A, Liu Y, Lo JW, Crawford JD, Sachdev PS (2021) Resveratrol: a miracle drug in neuropsychiatry or a cognitive enhancer for mice only? A systematic review and meta-analysis. Ageing Res Rev 65:101199. https://doi.org/10.1016/j.arr.2020.101199

Article  CAS  PubMed  Google Scholar 

Mahdavi A, Bagherniya M, Mirenayat MS, Atkin SL, Sahebkar A (2021) Medicinal plants and phytochemicals regulating insulin resistance and glucose homeostasis in type 2 diabetic patients: a clinical review. Adv Exp Med Biol 1308:161–183. https://doi.org/10.1007/978-3-030-64872-5_13

Article  CAS  PubMed  Google Scholar 

Sun ZM, Guan P, Luo LF, Qin LY, Wang N, Zhao YS, Ji ES (2020) Resveratrol protects against CIH-induced myocardial injury by targeting Nrf2 and blocking NLRP3 inflammasome activation. Life Sci 245:117362. https://doi.org/10.1016/j.lfs.2020.117362

Article  CAS  PubMed  Google Scholar 

Ji K, Li Z, Lei Y, Xu W, Ouyang L, He T, Xing Y (2021) Resveratrol attenuates retinal ganglion cell loss in a mouse model of retinal ischemia reperfusion injury via multiple pathways. Exp Eye Res 209:108683. https://doi.org/10.1016/j.exer.2021.108683

Article  CAS  PubMed  Google Scholar 

Sun YY, Zhu HJ, Zhao RY, Zhou SY, Wang MQ, Yang Y, Guo ZN (2023) Remote ischemic conditioning attenuates oxidative stress and inflammation via the Nrf2/HO-1 pathway in MCAO mice. Redox Biol 66:102852. https://doi.org/10.1016/j.redox.2023.102852

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Xu P, Hong Y, Xie Y, Peng M, Sun R, Guo H, Zhang X et al (2023) Lipocalin-2-mediated astrocyte pyroptosis promotes neuroinflammatory injury via NLRP3 inflammasome activation in cerebral ischemia/reperfusion injury. J Neuroinflammation 20(1):148. https://doi.org/10.1186/s12974-023-02819-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu R, Luo H, Ji Y, Wang Z, Zheng P, Ouyang H, Wang X, Wang Y et al (2023) Activation of NLRP3 signaling contributes to cadmium-induced bone defects, associated with autophagic flux obstruction. Sci Total Environ 893:164787. https://doi.org/10.1016/j.scitotenv.2023.164787

Article  CAS  PubMed  Google Scholar 

Yang J, Yang N, Luo J, Cheng G, Zhang X, He T, Xing Y (2020) Overexpression of S100A4 protects retinal ganglion cells against retinal ischemia-reperfusion injury in mice. Exp Eye Res 201:108281. https://doi.org/10.1016/j.exer.2020.108281

Article  CAS  PubMed  Google Scholar 

Franke M, Bieber M, Kraft P, Weber A, Stoll G, Schuhmann MK (2021) The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice. Brain Behav Immun 92:223–233. https://doi.org/10.1016/j.bbi.2020.12.009

Article  CAS  PubMed  Google Scholar 

Tang TT, Lv LL, Pan MM, Wen Y, Wang B, Li ZL, Wu M, Wang FM et al (2018) Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation. Cell Death Dis 9(3):351. https://doi.org/10.1038/s41419-018-0378-3

Article  CAS  PubMed  PubMed Central